Clinical Trial: ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Knee Osteoarthritis
Study Type: INTERVENTIONAL
Official Title: ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
Brief Summary:
This study is a prospective, multicenter (up to 4 sites), randomized, double-blind, two-arm study.Forty-five (45) patients will be randomized to receive a single 4-6 ml intra-articular (IA) injection of either the output of ACP Max™ (n=30) or 6 ml of Depo-Medrol® (methylprednisolone acetate) (n=15).
Read more